Tag Archives: ISNS

Best Small Cap Stocks For 2021

Summit Trail Advisors LLC boosted its holdings in shares of Sony Corp (NYSE:SNE) by 1,217.3% in the 1st quarter, Holdings Channel reports. The firm owned 30,944 shares of the company’s stock after buying an additional 28,595 shares during the period. Summit Trail Advisors LLC’s holdings in Sony were worth $1,450,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Braun Bostich & Associates Inc. acquired a new position in shares of Sony during the first quarter worth $115,000. Bronfman E.L. Rothschild L.P. increased its holdings in shares of Sony by 87.7% during the first quarter. Bronfman E.L. Rothschild L.P. now owns 3,039 shares of the company’s stock worth $147,000 after buying an additional 1,420 shares in the last quarter. Rainier Group Investment Advisory LLC acquired a new position in shares of Sony during the first quarter worth $168,000. Strategic Global Advisors LLC acquired a new position in shares of Sony during the first quarter worth $254,000. Finally, Seven Eight Capital LP acquired a new position in shares of Sony during the first quarter worth $276,000. Hedge funds and other institutional investors own 6.87% of the company’s stock.

Best Small Cap Stocks For 2021: Image Sensing Systems, Inc.(ISNS)

Image Sensing Systems, Inc. develops and markets software-based computer enabled detection products and solutions for the intelligent transportation systems industry, and adjacent security and law enforcement markets. The company operates through three segments: Intersection, Highway, and License Plate Recognition (LPR). Its video and radar processing products are used in traffic, security, police, and parking applications, such as intersection control, highway, bridge and tunnel traffic management, venue security, entry control, LPR, and traffic data collection. The company offers various vehicle and traffic detection products, such as Autoscope video systems and RTMS radar systems that convert sensory input collected by video cameras and radar units into vehicle detection and traffic data used to operate, monitor, and improve the efficiency of roadway infrastructure; and Autoscope LPR systems, which use video sensors in the visible and infrared spectrums to read license or number plates for security, police, and parking applications. It also offers CitySync, a rapid plate recognition technology, which reads a license plate and uses various methods for optical character recognition and plate finding for each plate read. The company sells its products to end users comprising federal, state, city, and county departments of transportation, port, highway, tunnel, and other transportation authorities; law enforcement agencies; and parking facility operators, as well as system integrators or other suppliers of systems and services that are operating under subcontracts in connection with road construction contracts. Image Sensing Systems, Inc. was founded in 1984 and is headquartered in St. Paul, Minnesota.

Advisors’ Opinion:

  • [By Logan Wallace]

    Abaxis (NASDAQ: ABAX) and Image Sensing Systems (NASDAQ:ISNS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, valuation, risk and analyst recommendations.

  • [By Logan Wallace]

    Trimble (NASDAQ: TRMB) and Image Sensing Systems (NASDAQ:ISNS) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

  • [By Lisa Levin]


    Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results.
    Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results.
    SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss.
    Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday.
    Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million.
    Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today.
    ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79.
    Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss.
    Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss.
    iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results.
    Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97.
    Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15.
    AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings.
    Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49.
    Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday.
    Myomo, Inc. (NYSE: MYO) slipp

Best Small Cap Stocks For 2021: OncoMed Pharmaceuticals, Inc.(OMED)

OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, discovers and develops protein therapeutics targeting cancer stem cells (CSCs). Its product candidates target CSCs by blocking self-renewal and driving differentiation of CSCs toward a non-tumorigenic state, as well as impact bulk tumor cells. The companys product candidates and preclinical programs include Demcizumab (Anti-DLL4, OMP-21M18), a humanized monoclonal antibody that is in two Phase II clinical trials and one Phase Ib/II clinical trial for the treatment of patients with non-small-cell lung cancer and pancreatic cancer; Anti-DLL4/Anti-vascular endothelial growth factor (VEGF) Bispecific, which has completed preclinical trial that targets and inhibits DLL4 and vascular endothelial growth factor (VEGF); Tarextumab (Anti-Notch2/3, OMP-59R5), a human monoclonal antibody that targets the Notch2 and Notch3 receptors that is in Phase II clinical trials; Brontictuzumab (Anti-Notch1, OMP-52M51), a human monoclonal antibody, which completed single-agent Phase I trial for the treatment of solid tumor; and Vantictumab ((Anti-Fzd7, OMP-18R5) that completed a Phase I single-agent trial in tumor patients. Its products also include Ipafricept (Fzd8-Fc, OMP-54F28), a fusion protein based Frizzled8 receptor or Fzd8, which is in Phase I single agent trial; Wnt biologic #3, an additional bispecific biologic product candidate in preclinical studies; Wnt small molecule inhibitors, which is in preclinical testing; and RSPO-LGR, a CSC pathway that is in preclinical study of antibodies. OncoMed Pharmaceuticals, Inc. has strategic alliances with GlaxoSmithKline LLC to develop anti-CSC antibody therapeutics targeting the Notch signaling pathway; Bayer Pharma AG for anti-CSC biologic and small molecule therapeutics targeting the Wnt signaling pathway; and Celgene Corporation for anti-CSC product candidates. The company was founded in 2004 and is headquartered in Redwood City, California.

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the headlines that may have impacted Accern Sentiment Analysis’s rankings:

    Get Oncomed Pharmaceuticals alerts:

    Recent Technicals: OncoMed Pharmaceuticals (NASDAQ: OMED) (reagentsglobalmarket.com) OncoMed Pharmaceuticals, Inc. (NasdaqGS:OMED) Book to Market Valuation Stands at 0.479899 (vassarnews.com) Zacks: Analysts Expect Oncomed Pharmaceuticals Inc (OMED) Will Announce Quarterly Sales of $7.97 Million (americanbankingnews.com) Oncomed Pharmaceuticals Inc (OMED) Expected to Post Earnings of -$0.20 Per Share (americanbankingnews.com) Oncomed Pharmaceuticals Inc (OMED) Receives Average Rating of “Hold” from Analysts (americanbankingnews.com)

    Several brokerages have weighed in on OMED. Zacks Investment Research cut shares of Oncomed Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Tuesday, August 21st. ValuEngine raised shares of Oncomed Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research note on Wednesday, May 2nd. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $4.30.

Best Small Cap Stocks For 2021: Polo Ralph Lauren Corporation(RL)

Ralph Lauren Corporation, together with its subsidiaries, engages in the design, marketing, and distribution of lifestyle products. The company offers men?s, women?s, and children?s clothing; and accessories comprising footwear, eyewear, watches, jewelry, hats, and belts, as well as leather goods, including handbags and luggage. It also provides products for homes, including bedding and bath products, furniture, fabric and wallpaper, paint, tabletop, and giftware; and fragrance products for women men. In addition, the company licenses its products, such as men?s sportswear, men?s tailored clothing, men?s underwear and sleepwear, eyewear, fragrances, cosmetics, and color and skin care products. It offers its products under the Polo by Ralph Lauren, Ralph Lauren Purple Label, Ralph Lauren Women?s Collection, Black Label, Blue Label, Lauren by Ralph Lauren, RRL, RLX, Rugby, Ralph Lauren Childrenswear, American Living, Chaps, and Club Monaco brand names. Ralph Lauren sells its products to department stores, specialty stores, and golf and pro shops; full-price retail stores, factory retail stores, and concessions-based shop-within-shops; and online through RalphLauren.com and Rugby.com. As of April 3, 2010, it operated 179 full-price retail stores and 171 factory stores worldwide, as well as 281 concessions-based shop-within-shops and 2 e-commerce Websites. The company was formerly known as Polo Ralph Lauren Corporation and changed its name to Ralph Lauren Corporation in August 2011. Ralph Lauren Corporation was founded in 1967 and is based in New York, New York.

Advisors’ Opinion:

  • [By Leo Sun]

    Shares of Ralph Lauren (NYSE:RL)rallied 8% onFeb. 5 after the apparel retailer’s third quarter numbers topped Wall Street’s expectations. Its revenue rose 5% annually (6% on a constant currency basis) to $1.73 billion and beat estimates by $70 million. Its non-GAAP EPS climbed 14% to $2.32, topping expectations by $0.17.

  • [By Daniel Miller]

    Shares of Ralph Lauren Corporation (NYSE:RL) were up 7% as of 12:18 p.m. EST after the company released strong results for the third quarter of fiscal 2019. The company is a global designer, marketer, and distributor of premium products in apparel, home, accessories, and fragrances.

  • [By Motley Fool Transcribers]

    Ralph Lauren Corp (NYSE:RL)Q32019 Earnings Conference CallFeb. 05, 2019, 9:00 a.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


  • [By Garrett Baldwin]

    Click here to learn more…

    Stocks to Watch Today: DIS, TMUS, BP, S
    Shares of Walt Disney Co. (NYSE: DIS) will lead a busy day of earnings reports. Wall Street is expecting a small decline in revenue for the first quarter. Disney is still in the process of absorbing most of Fox’s assets from a deal last June. In addition, Disney will be launching its streaming service, Disney+, and investors will be looking for updates on the project. In deal news, T-MobileU.S. Inc. (NYSE: TMUS) is looking to sweeten an offer to regulators to ensure a merger with rival Sprint Corp. (NYSE: S). The telecom giant told the U.S. Federal Communications Commission that it would freeze the prices of many plans if it receives approval for a deal. T-Mobile has offered $26 billion to buy Sprint. Shares of BP Plc. (NYSE: BP) rallied more than 3.7% after the global energy giant topped 2018 earnings expectations. The firm’s big bets on shale developments have paid off. Profitability more than doubled over the previous year, while production topped out at 3.7 million barrels per day. Look for earnings reports from Allstate Corp.(NYSE: ALL), Anadarko Petroleum Corp. (NYSE: APC), Archer Daniels Midland Co. (NYSE: ADM), Becton, Dickenson & Co. (NYSE: BDX), BP Plc.(NYSE: BP), Chubb Ltd.(NYSE: CB), Digital Realty Trust (NYSE: DLR), Emerson Electric Co. (NYSE: EMR), Estee Lauder Co. Inc. (NYSE: EL), Lazard Ltd.(NYSE: LAZ), Pitney Bowes Inc. (NYSE: PBI), Plains All American Pipeline LP (NYSE: PAA), Ralph Lauren Corp. (NYSE: RL), Snap Inc. (NYSE: SNAP), and Tableau Software Inc. (NASDAQ: DATA).

    Follow Money MorningonFacebook, Twitter, and LinkedIn.